Property-Based Design of Xanthine Derivatives as Potent and Orally Available TRPC4/5 Inhibitors for Depression and Anxiety
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Zhaoxiang Song und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Drug Design, Depression, Anxiety, Antidepressive Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Plan Projects of Tibet Autonomous Region, ?Double First-Class? University Projects.
Themen: Depression
Abstract (Originalsprache)
Transient receptor potential canonical channels 4 and 5 (TRPC4/5) are nonselective cation channels involved in emotional regulation, positioning them to be promising targets for treating mental disorders such as anxiety and depression. HC-070, a potent TRPC4/5 inhibitor, exhibits significant anxiolytic and antidepressant effects in animal models, though its drug-like properties require optimization. In this study, we applied a property-based drug design (PBDD) approach to optimize HC-070, leading to the discovery of compound 32, which shows improved LipE and Fsp3 values, reduced hERG blocking activity, enhanced metabolic stability, increased aqueous solubility, and superior oral bioavailability. Oral administration of compound 32 in mouse models demonstrates anxiolytic and antidepressant efficacy comparable to fluoxetine. This study supports the therapeutic potential of TRPC4/5 inhibitors for mental disorders and identifies compound 32 as a promising candidate for further investigation. Furthermore, our work underscores the value of PBDD in optimizing lead compounds during drug discovery process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu…
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210046, China.
ORCID-Profile: Jianhua Shen, Kai Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Plan Projects of Tibet Autonomous Region
- ?Double First-Class? University Projects
Zitieren
APA
Song, Z., Liang, H., Xue, C., Wang, S., Ren, Y., Zhang, Z., Xu, T., Niu, B., Song, M., Liu, M., Qin, X., Li, J., Zhao, X., Zhao, F., Shen, J., Cao, Z., & Wang, K. (2025). Property-Based Design of Xanthine Derivatives as Potent and Orally Available TRPC4/5 Inhibitors for Depression and Anxiety. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02870
Vancouver
Song Z, Liang H, Xue C, Wang S, Ren Y, Zhang Z, et al. Property-Based Design of Xanthine Derivatives as Potent and Orally Available TRPC4/5 Inhibitors for Depression and Anxiety. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02870
BibTeX
@article{Song2025,
author = {Song, Zhaoxiang and Liang, Huaduan and Xue, Chu and Wang, Shuxian and Ren, Younan and Zhang, Zhuang and Xu, Tifei and Niu, Bo and Song, Mengmeng and Liu, Mengru and Qin, Xu and Li, Jie and Zhao, Xianya and Zhao, Fang and Shen, Jianhua and Cao, Zhengyu and Wang, Kai},
title = {Property-Based Design of Xanthine Derivatives as Potent and Orally Available TRPC4/5 Inhibitors for Depression and Anxiety},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02870}
}
EUVIMED